SUDEEPPHRM — Sudeep Pharma Income Statement
0.000.00%
Last trade - 00:00- IN₹74.94bn
- IN₹75.79bn
- IN₹4.97bn
Annual income statement for Sudeep Pharma, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS |
| Standards: | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 3,430 | 4,262 | 4,547 | 4,974 |
| Cost of Revenue | ||||
| Gross Profit | 1,986 | 2,255 | 2,752 | 3,171 |
| Selling / General / Administrative Expenses | ||||
| Depreciation and Amortization | ||||
| Other Operating Expenses | ||||
| Total Operating Expenses | 2,806 | 3,475 | 2,859 | 3,213 |
| Operating Profit | 625 | 787 | 1,688 | 1,762 |
| Gain / Loss on Sale of Assets | ||||
| Total Net Non Operating Interest Income / Expense | ||||
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | 685 | 860 | 1,748 | 1,828 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | 498 | 623 | 1,331 | 1,387 |
| Net Income Before Extraordinary Items | ||||
| Net Income | 498 | 623 | 1,331 | 1,387 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | 498 | 623 | 1,331 | 1,387 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | 4.41 | 5.52 | 11.8 | 12.3 |
| Dividends per Share |